Pre-clinical evaluation of probes to detect t(8;21) AML minimal residual disease by fluorescence in situ hybridization

Genes Chromosomes and Cancer

Volumn 21, Issue 2, 1998, Pages 144-151

  Paskulin, Giorgio A ^a,f   Philips, George ^a   Morgan, Rodman ^c   Sandberg, Avery ^c   Richkind, Kathleen ^c   Borovik, Cleide ^e   McGavran, Loris ^b   Rabinovich, Nonna ^d   Dietz Band, Jeanne ^d   Erickson, Paul ^a   Drabkin, Harry ^a   Varella Garcia, Marileila ^a,g  

^a UNIVERSITY OF COLORADO   (United States)

^b Colorado Genetics Laboratory ^*  (United States)

^c GENZYME GENETICS   (United States)

^d Oncor Inc   (United States)

^e Hereditas   (Brazil)

^f FFCM   (Brazil)

^g UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ALLELE; ARTICLE; CELL DENSITY; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CONTROLLED STUDY; COSMID; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; X CHROMOSOME; Y CHROMOSOME; YEAST ARTIFICIAL CHROMOSOME;

BONE MARROW CELLS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA PROBES; FLUORESCENT DYES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOCYTIC, ACUTE; NEOPLASM, RESIDUAL; ONCOGENE PROTEINS, FUSION; RECOMBINANT FUSION PROTEINS; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0031889231     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199802)21:2<144::AID-GCC10>3.0.CO;2-R     Document Type: Article

References (29)

1. Asou H, Tashiro S, Hamamoto K, Otsuji A, Kita K, Kamada M (1991) Establishment of a human acute mycloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. Blood 77:2031-2036.
2. Campana D, Pui CH (1995) Detection of minimal residual disease in acute leukemia: Methodologic advances and clinical significance. Blood 85:1416-1434.
3. Chang K-S, Fan YH, Stass SA, Estey EH, Wang G, Trujillo JM, Erickson P, Drahkin H (1993) Expression of AML1-ETO fusion transcripts and detection of minimal residual disease in t(8;21)-positive acute myeloid leukemia. Oncogene 8:983-988.
4. Cherif D, Julier C, Delattre O, Derré J, Lathrop GM, Berger R (1990) Simultaneous localization of cosmids and chromosome R-banding by fluorescence microscopy: Application to regional mapping of human chromosomes. Proc Natl Acad Sci USA 87:6639-6643.
5. Chumakov IM, Rigault P, LeGall I, Bellanné-Chantelot C, Billaut A, Guillou S, Soularue P, Guasconi G, Pouillier E, Gros I, Belova M, Sambucy J-L, Susini L, Gervy P, Gliberti F, Beaufils S, Bui H, Massart C, DeTand MF, Dukasz F, Lecoulant S, Ougen P, Perrot V, Saumier M, Soravito C, Bahouayila R, Cohen-Akenine A, Barillot E, Bertrand S, Codani JJ, Caterina D, Georges I, Lacroix B, Lucotte G, Sahbatou M, Schmit C, Sangouard M, Tubacher E, Dib C, Faure S, Fizames C, Gyapay G, Millasseau F, Nguien S, Muselet D, Vignal A, Morisette J, Menninger J, Lieman J, Desai T, Banks M, Bray-Ward P, Ward D, Hudson T, Gerety S, Foote S, Stein L, Page DC, Lander ES, Weissenbach J, LePaslier D, Cohen D (1995) A YAC contig map of the human genome. Nature 377 (Suppl):175-197.
6. Downing JR, Head DR, Curcio-Brint AM, Hulshof MG, Motroni TA, Raimondi SC, Carroll AJ, Drabkin HA, Willman C, Theil KS, Civin CI, Erickson P (1993) An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation. Blood 81:2860-2865.
7. Erickson P, Gao J, Chang KS, Look T, Whisenant E, Raimondi S, Lasher R, Trujilo J, Rowley J, Drabkin H (1992) Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 80:1825-1831.
8. Erickson PF, Dessev G, Lasher RS, Philips G, Robinson M, Drabkin HA (1996) ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: Implications for t(8;21 ) leukemogenesis and monitoring residual disease. Blood 88:1813-1823.
9. Fischer K, Scholl C, Sàlat J, Fröhling S, Schlenk R, Bentz M, Stilgenbauer S, Lichter P, Döhner H (1996) Design and validation of DNA probe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia. Blood 88:3962-3971.
10. Gao J, Erickson P, Patterson D, Jones C, Drabkin H (1991) Isolation and regional mapping of NotI and EagI clones from human chromosome 21. Genomics 10:166-172.
11. Ghossein RA, Rosai J (1996) Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 78:10-16.
12. Guerrasio A, Rosso C, Martinelli G, Coco FL, Pampinella M, Santoro A, Lanza C, Allione B, Resegotti L, Saglio G (1995) Polyclonal haematopoieses associated with long-term persistence of the AML1/ETO transcript in patients with FAB M2 acute myeloid leukemia in continuous clinical remission. Br J Haematol 90:364-368.
13. Jurlander J, Caligiuri MA, Ruutu T, Baer MR, Strout MP, Oberkircher AR, Hoffmann L, Ball ED, Frei-Lahr DA, Christiansen NP, Block AW, Knuutila S, Herzig GP, Bloomfield CD (1996) Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood 88:2183-2191.
14. Le Beau MM (1993) Detecting genetic changes in human tumor cells: Have scientists "gone fishing?" Blood 81:1979-1983.
15. Maruyama F, Stass SA, Estey EH, Cork A, Hirano M, Ino T, Freireich EJ, Yang P, Chang KS (1994) Detection of AML1/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia. Leukemia 8:40-45.
16. Maseki N, Miyoshi H, Shimizu K, Homma C, Ohki M, Sakurai M, Kaneko Y (1993) The 8;21 chromosome translocation in acute myeloid leukemia is always detectable by molecular analysis using AML1. Blood 6:1573-1579.
17. Mitelman F, Heim S (1992) Quantitative acute leukemia cytogenetics. Genes Chromosomes Cancer 5:57-66.
18. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko V, Ohki M (1991) t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 88:10431-10434.
19. Muto A, Mori A, Matsuhita H, Awaya N, Ueno H, Takayama N, Okamoto S-I, Kizaki M, Ikeda Y (1996) Serial quantification of minimal residual disease of t(8:21) acute myelogenous leukaemia with RT-competitive PCR assay. Br J Haematol 95:85-94.
20. Nucifora O, Birn DJ, Erickson P, Gao J, Le Beau MM, Drabkin HA, Rowley JD (1993a) Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia. Blood 81:883-888.
21. Nucifora G, Larson RA, Rowley JD (1993b) Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood 82:712-715.
22. Sacchi N, Magnani I, Kearney L, Wijsman J, Hagemeijer A, Darfler M (1995) Interphase cytogenetics of the t(8;21)(q22;22) associated with acute myelogenous leukemia by two-color fluorescence in situ hybridization. Cancer Genet Cytogenet 79:97-103.
23. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
24. Saunders MJ, Tobal K, Liu Yin JA (1994) Detection of t(8;21) by reverse transcriptase polymerase chain reaction in patients in remission of acute myeloid leukemia type M2 after chemotherapy or bone marrow transplantation. Leukemia Res 18:891-895.
25. Sherman F, Fink GR, Hichs JB (1986) Methods in Yeast Genetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
26. Shimizu K, Miyoshi H, Kozu T, Nagata J, Enomoto K, Maseki N, Kaneko Y, Ohki M (1992) Consistent disruption of the AML1 gene occurs within a single intron in the t(8;21) chromosomal translocation. Cancer Res 52:6945-6948.
27. Tighe JE, Daga A, Calabi F (1993) Translocation breakpoints are clustered on both chromosome 8 and chromosome 21 in the t(8;21) of acute myeloid leukemia. Blood 81:592-596.
28. Tobal K, Yin JAL (1996) Monitoring of minimal residual disease by quantitative reverse transcriptase-polymerase chain reaction for AML1-MTG8 transcripts in AML-M2 with t(8;21 ). Blood 88:3704-3709.
29. Zhang T, Hillion J, Tong JH, Cao O, Chen SJ, Berger R, Chen Z (1994) AML 1 gene rearrangement and AML1/ETO gene expression as molecular markers of acute myeloblastic leukemia with t(8;21). Leukemia 8:729-734.